Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T7UG
|
|||
| Former ID |
DNC013880
|
|||
| Drug Name |
N-(2,3-dihydro-1H-inden-2-yl)isoquinolin-1-amine
|
|||
| Synonyms |
CHEMBL470205; N-(2,3-dihydro-1H-inden-2-yl)isoquinolin-1-amine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H16N2
|
|||
| Canonical SMILES |
C1C(CC2=CC=CC=C21)NC3=NC=CC4=CC=CC=C43
|
|||
| InChI |
1S/C18H16N2/c1-2-7-15-12-16(11-14(15)6-1)20-18-17-8-4-3-5-13(17)9-10-19-18/h1-10,16H,11-12H2,(H,19,20)
|
|||
| InChIKey |
LJNDWVYBQFLXJV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2190-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.